ES CN EN
Current location:Home Product Center POCT Respiratory Disease
Introduction
Product Features
Specification
Q&A
Flu A/B + COVID-19 Antigen Combo Test Cassette Kit
Differentiation of Influenza A Virus, Influenza B Virus, and COVID-19 Virus
The test is intended for use in the simultaneous rapid in vitro detection and differentiation of influenza A virus, influenza B virus, and COVID-19 virus nucleocapsid protein antigen, but does not differentiate, between SARS-CoV and COVID-19 viruses and is not intended to detect influenza C antigens. Performance characteristics may vary against other emerging influenza viruses.
Product manual
Download Browse
Introduction
Product Features
Specification
Q&A
Introduction

Influenza A, influenza B, and COVID-19 viral antigens are generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status.


Introduction More
Product Features
Specification
Product Name
Flu A/B + COVID-19 Antigen Combo Test Cassette Kit
Package Specification
20 tests/kit
Storage Condition

Store as packaged in the sealed pouch at room temperature or refrigerated (4-30°C).


Performance

1. Sensitivity and Specificity of Flu A

The total sensitivity of Flu A is 100.0%; 95% CI:(97.9% - 100.0%)

Total specificity of Flu A from the above table is 99.4%; 95%Cl: (88.3%-100.0%)

 

2. Sensitivity and Specificity of Flu B

The Flu A/B Test Cassette (nasopharyngeal Swab Specimen) was compared with a commercial PCR.

The total sensitivity of Flu B is 100.0%; 95% CI:(81.5% - 100.0%)

Total specificity of Flu B from the above table is 99.4%; 95%Cl: (88.3%-100.0%)


Q & A
You may be interested in: